DIA Biosimilars 2013

Epic Sciences

Epic Sciences completes $13M Series B financing to advance cancer diagnostics

Wednesday, November 14, 2012 12:01 PM

Epic Sciences, a La Jolla, Calif.-based private biotech company that develops breakthrough cancer diagnostics, completed a $13 million Series B equity financing. This financing includes new investors Domain Associates, Roche Venture Fund and Pfizer Venture Investments, in addition to undisclosed individual investors.

More... »

Cenduit: Now with Patient Reminders

Six pharmas employing Epic Sciences’ circulating tumor cell technology

Wednesday, August 15, 2012 10:38 AM

Epic Sciences, a privately held cancer diagnostics company of La Jolla, Calif., has established collaborations with six pharmaceutical partners employing Epic’s proprietary Circulating Tumor Cell (“CTC”) technology.

More... »

CRF Health – eCOA Forum
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs